ZYDUS PHARMS USA INC FDA Approval ANDA 211582

ANDA 211582

ZYDUS PHARMS USA INC

FDA Drug Application

Application #211582

Documents

Letter2020-12-07

Application Sponsors

ANDA 211582ZYDUS PHARMS USA INC

Marketing Status

None (Tentative Approval)001
Prescription002

Application Products

001TABLET;ORAL5MG0DAPAGLIFLOZINDAPAGLIFLOZIN
002TABLET;ORAL10MG0DAPAGLIFLOZINDAPAGLIFLOZIN

FDA Submissions

UNKNOWN; ORIG1TA2020-10-28STANDARD

Submissions Property Types

ORIG1Null31

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

ZYDUS PHARMS USA INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 211582
            [companyName] => ZYDUS PHARMS USA INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"DAPAGLIFLOZIN","activeIngredients":"DAPAGLIFLOZIN","strength":"UNKNOWN","dosageForm":"UNKNOWN","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/28\/2020","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-10-28
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.